Peak Dominance: Why Jacob deGrom Was Baseball's Most Unhittable Arm (2018–2021)

Before the injuries began to define his narrative, Jacob deGrom authored one of the most dominant four-year stretches in modern pitching history. From 2018 through 2021, no starter in baseball combined raw stuff with precision command as effectively as the Mets right-hander. His 2018 campaign remains a statistical marvel: a 1.70 ERA with 269 strikeouts across 217 innings, earning him the National League Cy Young Award despite a pedestrian 10-9 win-loss record that reflected the Mets' offensive struggles rather than his own performance.

The following season was no fluke. DeGrom posted a 2.43 ERA with 255 strikeouts and a 0.972 WHIP, securing his second consecutive Cy Young. What separated him from contemporaries like Max Scherzer or Justin Verlander was not just the triple-digit fastball but the sustainability of that velocity deep into starts. Through the first six innings of his outings, his average fastball velocity sat at 97.4 mph; it would often still touch 98 mph in the seventh and eighth. According to Baseball Reference, his 19.5 WAR from 2018–2021 led all MLB pitchers, surpassing even the American League's best arms.

DeGrom's arsenal during this period was a study in complementary pitch design. His four-seam fastball played up because of elite extension—he released the ball nearly six feet from the rubber—creating an effective velocity that registered faster than the radar gun suggested. His slider had horizontal break that mirrored his fastball's tunnel before darting away from right-handed hitters. The changeup, used only about 12% of the time, featured fading action that neutralized lefties. His whiff rate in 2020 reached 39.1%, a figure that approached the all-time single-season record for qualified starters. Opponents posted a barrel rate of just 4.2% against him during this stretch, the best in baseball by a wide margin.

What made the peak so compelling was its improbability. DeGrom was drafted in the ninth round out of Stetson University as a shortstop who converted to pitching late. He did not debut in the majors until age 26. He was never viewed as a can't-miss prospect. Yet by age 30, he had established himself as the game's most dominant pitcher, one whose starts were appointment viewing because of the very real possibility he might throw a no-hitter or strike out 15 batters. The expectation entering each season was that he would be the best pitcher on the planet. That expectation lasted exactly as long as his health allowed.

Anatomy of the Decline: A Detailed Injury Timeline

DeGrom's physical unraveling did not happen overnight. It was a slow erosion punctuated by sharp interruptions, each one taking something from his arsenal that he could never fully recover. The first significant warning sign arrived in July 2021, when he was placed on the injured list with right flexor tendinitis. At the time, he was in the midst of arguably the best season of his career: a 1.08 ERA, 146 strikeouts in 92 innings, and a 0.554 WHIP that was historically low. The injury cost him two months. When he returned in September, his fastball velocity had dropped from 98.8 mph to 96.1 mph, and his slider lost two inches of horizontal break. He made two starts before the season ended, posting a 3.60 ERA that hinted at a pitcher no longer operating at full capacity.

The 2022 season brought renewed hope and a fresh disaster. DeGrom opened the year on the injured list while recovering from a stress reaction in his right scapula, a shoulder injury that kept him out until August. After a rehab assignment, he returned to make 11 starts down the stretch. The early returns were encouraging—he struck out 12 batters in his first start back—but the consistency was gone. His average fastball velocity was down to 96.3 mph for the season, and his walk rate climbed to 6.1%, the highest it had been since 2017. He finished with a 3.08 ERA, excellent by any standard but a full run and a half higher than his 2021 peak. The shoulder issue had compromised not just his power but his ability to repeat his delivery.

The Tommy John Surgery Decision

Having declined the Mets' contract extension offers, deGrom signed a five-year, $185 million deal with the Texas Rangers in December 2022. The contract was widely viewed as a gamble given his age and injury history, but the Rangers were coming off a 94-loss season and needed a franchise anchor for their rotation. For the first six weeks of 2023, the gamble appeared to pay off: deGrom posted a 2.67 ERA with 45 strikeouts in 30.1 innings across six starts. His fastball was back to 97-98 mph, and his command looked sharp.

Then came the elbow soreness. An MRI revealed a tear in his right ulnar collateral ligament, and on June 12, 2023, deGrom underwent Tommy John surgery. The procedure, his first, typically requires a rehabilitation timeline of 12–18 months. For a 35-year-old pitcher, the surgery carried existential questions about whether he would ever again be the same pitcher. Historical data on Fangraphs shows that pitchers over 30 who undergo Tommy John surgery see an average decline of 1.5 mph in fastball velocity and a 0.6 increase in ERA upon return. For pitchers over 35, the outcomes are even more sobering.

DeGrom's recovery was methodical. He began throwing off a mound in July 2024 and progressed through simulated games before being activated on September 13, 2024, exactly 457 days after his last MLB appearance. The MLB.com report on his return emphasized the meticulous nature of his rehabilitation, but the box scores from his five starts in September told a more complicated story.

Breaking Down the Post-Recovery Performance Changes

Each injury has left a measurable imprint on deGrom's performance profile. The changes are not uniform—some metrics have recovered partially, while others have permanently shifted. A close examination of the data reveals a pitcher who is adapting, not declining into irrelevance, but whose ceiling has been lowered by the accumulated toll of major arm surgeries.

Velocity Decline and Recovery Patterns

The most visible change in deGrom's game is velocity. During his peak years from 2018–2021, his four-seam fastball averaged 97.2 mph, with the ability to reach 101 mph when he needed an extra gear. In his six starts before Tommy John surgery in 2023, that average had dropped to 94.5 mph, a decline of nearly 3 mph. Upon his return in September 2024, the velocity was even lower initially: his first two starts saw an average of 93.8 mph. However, as he built arm strength over the following weeks, his velocity ticked upward, reaching 96.8 mph in his final start of the season on September 29. The upward trend is encouraging, but it is important to note that he never touched 100 mph in any of his 2024 outings, and his average fastball velocity for his five starts was 94.2 mph.

Velocity is not just about power; it is also about pitch sequencing. A fastball at 97 mph plays differently than one at 94 mph because the hitter has less time to recognize the pitch and adjust to the breaking ball. The velocity drop has forced deGrom to rely more heavily on timing disruption rather than pure explosiveness. His fastball whiff rate fell from 27.4% in 2021 to 19.1% in his 2024 return, a decline that directly correlates with the reduction in velocity plus the decreased effectiveness of the fastball as a setup pitch for his secondary offerings.

Command Erosion and Walk Rate Spikes

Perhaps more concerning than the velocity dip is the erosion of deGrom's elite command. Control had always been his secret weapon; he walked only 5.4% of batters during his peak years, a rate that placed him among the top 10% of qualified starters. After each injury, that control has taken time to return. Following the 2021 flexor injury, his walk rate rose to 6.2% over his final two starts. After the 2022 shoulder injury, it climbed to 6.5% in September. In his 2024 return from Tommy John surgery, the walk rate jumped to 8.9% across 19.1 innings, a figure that would rank among the worst in baseball if sustained over a full season.

The command issues are most pronounced with his secondary pitches. DeGrom's slider, once a weapon he could place on either corner of the strike zone, saw its zone rate drop from 48% in 2021 to 42% in his 2024 sample, as tracked by Fangraphs pitch data. His changeup, meanwhile, was left in the zone too often, resulting in a .267 batting average against compared to a .143 average in 2021. The reduced command stemmed partly from mechanical adjustments: deGrom shortened his arm path post-surgery to reduce stress on the elbow, which altered his release point and changed the movement profile of his pitches. Analysts noted that his extension, once among the best in baseball at 6.3 feet, had shrunk to 5.8 feet, giving hitters more time to read his pitches out of the hand.

Strikeout Decline and Contact Management

The most significant statistical shift in deGrom's post-injury profile is the reduction in strikeouts. His strikeout rate peaked at 11.3 K/9 in 2020 and was 11.1 K/9 in 2021. After returning from Tommy John surgery, that rate dropped to 7.9 K/9, a decline of nearly three strikeouts per nine innings. His whiff rate fell from 15.2% to 11.4%, and his chase rate on pitches outside the zone dropped from 36% to 30%. Hitters are making more contact, and they are doing so with better quality: his barrel rate rose from 3.1% in 2021 to 6.8% in 2024, and his hard-hit rate jumped from 27% to 34%.

The strikeout decline is not merely a function of velocity. It also reflects a strategic shift in how deGrom approaches at-bats. In his prime, he attacked hitters relentlessly in the strike zone, challenging them with premium velocity and trusting his stuff to get swings and misses. Now, he is more inclined to pitch to contact, hoping to induce weak ground balls and pop-ups rather than strikeouts. His ground ball rate actually improved in 2024, rising to 46% from a career average of 43%, suggesting that his new approach is producing the desired contact profile. But the trade-off is that he can no longer escape jams with a strikeout, putting more pressure on his defense and increasing his risk of big innings.

Pitch Mix Overhaul: The Cutter Experiment

Perhaps the most telling adaptation in deGrom's post-injury repertoire is the introduction of a cut fastball. Before 2024, deGrom had thrown a cutter only occasionally, as a show-me pitch. In his return from surgery, he threw the cutter 12% of the time, effectively using it as a replacement for some of his fastball usage. The cutter sits at 89-91 mph with late glove-side movement, providing a different look for hitters who were sitting on the slider or four-seam fastball.

The analytics behind the cutter are compelling. According to analysis on Savagemagazine.com, the cutter generates weaker contact than his four-seam fastball and puts less stress on the elbow because it does not require the same forearm supination as the slider. DeGrom's four-seam usage dropped from 55% in his prime to 43% in 2024, while his slider usage increased to 38%. The cutter effectively gives hitters a third breaking look, making it harder to sit on any one pitch. However, the reduced fastball usage also means deGrom cannot set up his slider as effectively, and hitters are more inclined to lay off the breaking ball when they know the fastball is coming less frequently. The net result is a pitcher who is harder to square up but also harder to strike out.

Mental and Mechanical Adjustments in the Post-Injury Era

The physical changes to deGrom's game have been accompanied by equally significant mental and mechanical adaptations. The pitcher who once overwhelmed hitters with pure stuff has had to become a tactician, learning to sequence pitches rather than simply overpower them. Reports from his 2024 outings described a more deliberate, almost cerebral pitcher, one who studies scouting reports with renewed intensity and adjusts his plan from batter to batter rather than inning to inning.

DeGrom's mechanical changes are directly tied to his injury history. After Tommy John surgery, the Rangers' pitching coaches worked with him to shorten his arm path by approximately 15 degrees, reducing the amount of torque placed on his elbow. The modified delivery features a more compact arm circle and a lower arm slot, which helps protect the reconstructed UCL but also changes the angle at which hitters see the ball. The new delivery has cost him some of the extension that made his fastball seem faster than its velocity, but it may ultimately help him stay healthy longer. The trade-off, as noted by biomechanics experts, is that the lower arm slot makes his slider less sharp and his four-seam fastball more hittable up in the zone.

DeGrom has also altered his mental approach to pitching. He has described his post-injury mindset as "pitching smarter, not harder," a cliché that carries real meaning in his case. Instead of trying to strike out every batter, he now aims to induce weak contact early in counts, trusting his defense to make plays. This approach is more sustainable for a pitcher whose arm can no longer sustain high-effort innings, but it requires a level of command and precision that he is still working to reclaim. His pitch-to-contact strategy worked well in September 2024, when he induced a 52% ground ball rate, but it remains to be seen whether he can maintain that approach against elite lineups over a full season.

Future Outlook: What 2025 and Beyond Hold for deGrom

Entering the 2025 season, deGrom is a pitcher caught between two identities. The front office and coaching staff remember the 2018–2021 version and hope that with a full offseason of recovery, some of that dominance can be recaptured. The medical reality, however, suggests a different trajectory. Historical data on Tommy John surgery for pitchers over 35 reveals a sobering picture: according to research published in the American Journal of Sports Medicine, only 58% return to the majors, and those who do lose an average of 1.2 mph in velocity and see a 0.5 increase in ERA. DeGrom's early returns align closely with that pattern, though his elite mechanics and work ethic may push him toward the upper bound of outcomes.

Projection systems offer a measured view. Steamer and ZiPS both forecast deGrom to throw roughly 150 innings in 2025 with a 3.40 ERA, a 1.15 WHIP, and 9.0 strikeouts per nine. Those numbers would make him a solid number-two starter, a far cry from the Cy Young production of his prime but still a valuable contributor to a contending team. The Rangers, who won the World Series in 2023, have built their rotation around depth rather than a single ace, and deGrom's role is to provide quality innings rather than carry the staff.

Key Indicators for the 2025 Season

The first indicator of deGrom's trajectory will be his spring training velocity. If his fastball sits at 96 mph or above with regularity, it suggests his arm strength has returned to a competitive level. A velocity of 94-95 mph would confirm that his ceiling has permanently lowered. The second indicator is his command. If his walk rate stays in the 5-6% range, his command is back; if it hovers near 8-9%, he will struggle to pitch deep into games and will put constant pressure on his defense. The third indicator is durability. The Rangers plan to use a six-man rotation to manage his workload, but even with that buffer, deGrom has not thrown 150 innings in a season since 2019. If he can reach 160 innings in 2025, it would be a major victory for the organization.

The broader question for deGrom is whether he can evolve into a different kind of pitcher. The path is well-worn by other aging aces who adapted after losing velocity. Justin Verlander reinvented himself after Tommy John surgery at age 35, adding a slider and cutter to become a more pitch-to-contact oriented starter. Max Scherzer learned to sequence more effectively after his velocity declined. DeGrom's intelligence, work ethic, and willingness to change his repertoire suggest he can follow that path. But the physical toll of his injuries—not just the Tommy John surgery but the flexor tendinitis and scapula stress reaction—may have accumulated to a point where his body no longer responds the way it once did.

Lessons for Pitchers, Teams, and the Analytics Community

DeGrom's career arc offers a case study in the fragility of elite pitching. His contract with the Rangers, once viewed as a necessary gamble for a team desperate for an ace, now looks like a cautionary tale for clubs considering massive long-term deals for pitchers with injury histories. The Rangers are paying deGrom $37 million per year through 2027, and while insurance will cover a portion of his salary if he misses significant time, the opportunity cost of that money cannot be recovered. For teams like the Mets, who let deGrom walk rather than match the Rangers' offer, the decision looks prescient in hindsight.

For pitchers at all levels, deGrom's journey underscores the importance of monitoring arm health and addressing warning signs before they become catastrophic. The flexor tendinitis in 2021 and scapula stress reaction in 2022 were early indicators that his arm was under strain; the UCL tear in 2023 was the predictable outcome of accumulated stress. Modern biomechanical analysis can now identify pitchers at risk for UCL injuries by tracking changes in arm angle, elbow extension, and forearm pronation. The MLB's injury prevention initiatives are increasingly incorporating these metrics, and deGrom's case provides a real-world test of whether data-driven load management can extend careers.

The broader lesson is that even the most dominant pitchers can be humbled by injuries. DeGrom's peak was historically special, but the physical demands of throwing a baseball at maximum effort more than 100 times per game are simply unsustainable for most human arms. The pitchers who endure—the Verlanders, Sherzers, and Kershaws—are those who evolve their games as their bodies change. DeGrom is now embarked on that evolution. Whether he succeeds will determine not just his own legacy but the collective understanding of how elite pitchers can navigate the inevitable decline that comes with age and injury.

Jacob deGrom is no longer the untouchable ace of 2018. But he is still a major league pitcher with above-average stuff, elite intelligence, and a competitive drive that has not diminished. The 2025 season will reveal whether his adaptation can produce a new kind of dominance—less flashy, less overpowering, but effective in its own right. If he can stay healthy for 25 starts or more, expect a 3.20–3.60 ERA with a strikeout rate above 8.5 per nine. That may not be Cy Young caliber, but it is more than enough to make a contending team better. DeGrom's story is ultimately about resilience and reinvention, and his continued performance will be watched closely by fans, analysts, and every team trying to build a sustainable pitching staff.